Obstetrics/Gynecology
RSSArticles
-
Clinicians continue unneeded pelvic exams
Results of a new national survey of obstetricians and gynecologists (OB/GYNs) show that many physicians mistakenly believe a routine annual bimanual pelvic examination is important in screening for ovarian cancer. -
A decade past WHI — what have we learned?
Since the July 2002 publication of the first Women's Health Initiative (WHI) report, many changes have been made in the approach to hormone therapy (HT). -
Contraceptive Technology Update March 2013 Issue in PDF
-
Longer-acting method that is injectable probed
Contraceptive injectables are a popular form of birth control for women around the world, with more than 35 million women relying on the method. -
Pharmacology Watch: Do Perioperative Beta-Blockers Reduce Mortality?
Beta-blockers and noncardiac surgery; prenatal medication exposure and risk of autism; reasons for statin discontinuations; and FDA actions. -
Stroke Prevention by Screening for Atrial Fibrillation
Stepwise risk factor-stratified screening in an elderly population using a handheld ECG device detected a significant number of patients with silent paroxysmal atrial fibrillation. -
Infections May Play a Role in Cognitive Decline, Dementia
This study reports an association between infection burden and dementia, although the relationship may not be causal. -
Internal Medicine Alert - Full June 15, 2013 Issue in PDF
-
Chest Pain and Dyspnea? Taking Steroids? Think PE.
Corticosteroid use is associated with an increased risk of symptomatic pulmonary embolism. The greatest risk is in the first 30 days of use and increases with increasing steroid dose. -
Pharmacology Update: Fluticasone Furoate and Vilanterol Trifenatate Inhalation Powder (Breo Ellipta)
A new combination of an inhaled corticosteriod and a long-acting beta2-adrenergic agonist has been approved for the treatment of chronic obstructive pulmonary disease (COPD).